Its another buzzing day for investors in the primary markets as four companies have launched their initial public offerings worth more than Rs 3,600 crore open for subscription Devyani International, Windlas Biotech, Exxaro Tiles and Krsnaa Diagnostics have opened today August 4 and will close on August 6.
Devyani International, which operates KFC and Pizza Hut in India, and Krsnaa Diagnostics are emerging as the more favourite ones of experts of the four. Vinit Bolinjkar spoke to Money9 on how should investors decide to take their pick.
“Investors can bid for Krsnaa Diagnostics and Devyani International because both could make listing gains and are also good long-term bets”, he said.
“Looking at fundamentals as well as the flavour of the street at first glance, retail investors can bet on QSR (quick service restaurant) story Devyani International and Krsnaa Diagnostics for listing gains as well as long-term wealth-building stories.”, he added
He also believes that Windlas Biotech offers better chances for retail investors with higher reserved portion when compared to the previous two and is sound company with financials and valuations and can be a good bet for those looking to tap the pharmaceuticals (CDMO) space.
Its another buzzing day for investors in the primary markets as four companies have launched their initial public offerings worth more than Rs 3,600 crore open for subscription Devyani International, Windlas Biotech, Exxaro Tiles and Krsnaa Diagnostics have opened today August 4 and will close on August 6.
Devyani International, which operates KFC and Pizza Hut in India, and Krsnaa Diagnostics are emerging as the more favourite ones of experts of the four. Vinit Bolinjkar spoke to Money9 on how should investors decide to take their pick.
“Investors can bid for Krsnaa Diagnostics and Devyani International because both could make listing gains and are also good long-term bets”, he said.
“Looking at fundamentals as well as the flavour of the street at first glance, retail investors can bet on QSR (quick service restaurant) story Devyani International and Krsnaa Diagnostics for listing gains as well as long-term wealth-building stories.”, he added
He also believes that Windlas Biotech offers better chances for retail investors with higher reserved portion when compared to the previous two and is sound company with financials and valuations and can be a good bet for those looking to tap the pharmaceuticals (CDMO) space.
Download Money9 App for the latest updates on Personal Finance.